专利信息

查询条件展开筛选条件

[药品] 包含 'Aclidinium'

首页 1 2 3 4 5 下页尾页共 41 条记录, 当前第1/5页。

	公开号	公开日	申请号	申请日

首页 1 2 3 4 5 下页尾页共 41 条记录, 当前第1/5页。

当前查询条件: [药品] 包含 'Aclidinium'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. EP2696871A1	2014/2/19	EP20120712699	2012/4/11
专利标题：ACLIDINIUM FOR USE IN IMPROVING THE QUALITY OF SLEEP IN RESPIRATORY PATIENTS 专利权人：ALMIRALL SA [ES];

2. KR20140007929A	2014/1/20	KR20137025417	2012/4/11
专利标题：ACLIDINIUM FOR USE IN IMPROVING THE QUALITY OF SLEEP IN RESPIRATORY PATIENTS 专利权人：ALMIRALL SA [ES];

3. CN103476412A	2013/12/25	CN2012818637	2012/4/11
专利标题：Aclidinium for use in improving the quality of sleep in respiratory patients 专利权人：ALMIRALL SA;

4. TW201347788A	2013/12/1	TW20130118353	2013/5/24
专利标题：Novel dosage and formulation 专利权人：ALMIRALL SA [ES]; A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a delivered dose of aclidinium equivalent to about 322 micrograms aclidinium free base.

5. WO2013175013A1	2013/11/28	WO2013EP60808	2013/5/24
专利标题：NOVEL DOSAGE AND FORMULATION 专利权人：ALMIRALL SA [ES]; A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a delivered dose of aclidinium equivalent to about 322 micrograms aclidinium free base.

6. EP2666465A1	2013/11/27	EP20120382211	2012/5/25
专利标题：Novel dosage and formulation 专利权人：ALMIRALL SA [ES]; A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a delivered dose of aclidinium equivalent to about 322 micrograms aclidinium free base.

7. MX2013011772A	2013/11/1	MX20130011772	2013/10/9
专利标题：ACLIDINIUM FOR USE IN IMPROVING THE QUALITY OF SLEEP IN RESPIRATORY PATIENTS. 专利权人：ALMIRALL SA [ES]; The present invention provides aclidinium or any of its steroisomers or mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof, for improving the quality of sleep in respiratory patients.

8. AU2012241858A1	2013/8/15	AU20120241858	2012/4/11
专利标题：Aclidinium for use in improving the quality of sleep in respiratory patients 专利权人：ALMIRALL SA; The present invention provides aclidinium or any of its steroisomers or mixture of stereoisomers, or a pharmaceutically acceptable salt or solvate thereof, for improving the quality of sleep in respiratory patients.

9. US2013189317A1	2013/7/25	US201213692032	2012/12/3
专利标题：NOVEL DOSAGE AND FORMULATION 专利权人：ALMIRALL SA [ES];ALMIRALL SA [ES]; The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 400 micrograms aclidinium bromide.

10. US2013125884A1	2013/5/23	US201213672893	2012/11/9
专利标题：NOVEL DOSAGE AND FORMULATION 专利权人：ALMIRALL SA [ES];ALMIRALL SA [ES]; The present disclosure relates to pharmaceutical compositions for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 200 micrograms aclidinium bromide.

下载范围

下载内容